Current State of Development of Genome Analysis in Livestock
Journal:
Current Genomics
Volume:
4
Page:
487-525
Author(s):
Tanja Kutzer, Tosso Leeb and Bertram Brenig
Recurrence in Bladder Cancer: A Molecular Dead End?
Journal:
Current Genomics
Volume:
4
Page:
417-434
Author(s):
John M. S. Bartlett, Joanne Edwards and Ken M. Grigor
Structure-Function Relationships in the Interaction Between the Urokinase- Type Plasminogen Activator and Its Receptor
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1499-1528
Author(s):
Michael Ploug
Plasminogen Activator Inhibitor-1 in Tumor Growth, Angiogenesis and Vascular Remodeling
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1545-1564
Author(s):
Steingrimur Stefansson, Grainne A. McMahon, Eric Petitclerc and Daniel A. Lawrence
Virally Encoded G Protein-Coupled Receptors: Targets for Potentially Innovative Anti-Viral Drug Development
Journal:
Current Drug Targets
Volume:
4
Page:
431-441
Author(s):
J. M. Smit, C. Vink, D. Verzijl, P. Casarosa, A. C. Bruggeman and R. Leurs
Potential Drug Targets on the HIV-1 Envelope Glycoproteins, gp120 and gp41
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1453-1462
Author(s):
Li Huang, Linda Zhang and Chin Ho Chen
Highly Active Antiretroviral Therapy and Cardiovascular Complications in HIV-Infected Patients
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1475-1481
Author(s):
Giuseppe Barbaro and Edward C. Klatt
Bcl-2 Proteins: Targets and Tools for Chemosensitisation of Tumor Cells
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
307-318
Author(s):
Ali Bettaieb, Laurence Dubrez-Daloz, Sophie Launay, Stephanie Plenchette, Cedric Rebe, Severine Cathelin and Eric Solary
The Role of Iron Chelation in Cancer Therapy
Journal:
Current Medicinal Chemistry
Volume:
10
Page:
1021-1034
Author(s):
Joan L. Buss, Frank M. Torti and Suzy V. Torti
The MYC Oncogene as a Cancer Drug Target
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
163-175
Author(s):
Heiko Hermeking